Company / EPS (Diluted)
Valion Bio, Inc. EPS (Diluted) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$176.80
FY2024
5-year range
-$176.80 / -$2.43
FY2022-FY2024
Trend
-69.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-2.43 to $-176.80 over the past 2 years.
Based on SEC 10-K filings.
-176.80 in FY2024.
Declined from $-2.43 to $-176.80 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (diluted) decreased 69.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$176.80 | -69.5% |
| FY2023 | -$104.32 | -4193.0% |
| FY2022 | -$2.43 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026